Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Biosci Microbiota Food Health ; 43(3): 170-182, 2024.
Article in English | MEDLINE | ID: mdl-38966051

ABSTRACT

Cumulative evidence suggests that intermittent fasting (IF) has beneficial effects on human metabolic health. It has been indicated that its impact on the gut microbiota may mediate these beneficial effects. As a result, we hypothesized that IF may impact the human gut microbiota. A systematic review was carried out according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) protocol using the PubMed, Scopus, and CINAHL databases. We registered our systematic review protocol in PROSPERO under registration number CRD42021270050. Human intervention studies published until April 30, 2023, were included. The quality of the included studies was assessed using National Institutes of Health (NIH) quality assessment study tools for intervention studies. The search in the database returned 166 studies, of which 13 matched all criteria for the final qualitative analysis. The body of evidence suggests that IF modulates human gut microbiota alpha and beta diversity in lean (relatively healthy) and relatively healthy overweight/obese individuals but not in individuals with metabolic syndrome. Furthermore, IF also alters human gut microbiota composition in all phenotypes. Of interest, the gut microbiota taxa or microbial metabolites after an IF intervention are associated with metabolic markers. According to this review, IF influences the diversity and taxonomic levels of the human gut microbiota. Individual metabolic phenotypes may alter the effect of IF on the diversity and taxonomic levels of the gut microbiota.

2.
Front Immunol ; 14: 1122389, 2023.
Article in English | MEDLINE | ID: mdl-37404828

ABSTRACT

Introduction: Interim analysis of phase I and phase II clinical trials of personalized vaccines made from autologous monocyte-derived dendritic cells (DCs) incubated with S-protein of SARS-CoV-2 show that this vaccine is safe and well tolerated. Our previous report also indicates that this vaccine can induce specific T-cell and B cell responses against SARS-CoV-2. Herein, we report the final analysis after 1 year of follow-up regarding its safety and efficacy in subjects of phase I and phase II clinical trials. Methods: Adult subjects (>18 years old) were given autologous DCs derived from peripheral blood monocytes, which were incubated with the S-protein of SARS-CoV-2. The primary outcome is safety in phase I clinical trials. Meanwhile, optimal antigen dosage is determined in phase II clinical trials. Corona Virus Disease 2019 (COVID-19) and Non-COVID-19 adverse events (AEs) were observed for 1 year. Results: A total of 28 subjects in the phase I clinical trial were randomly assigned to nine groups based on antigen and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) dosage. In the phase II clinical trial, 145 subjects were randomly grouped into three groups based on antigen dosage. During the 1-year follow-up period, 35.71% of subjects in phase I and 16.54% in phase II had non-COVID AEs. No subjects in phase I experienced moderate-severe COVID-19. Meanwhile, 4.31% of subjects in phase II had moderate-severe COVID-19. There is no difference in both COVID and non-COVID-19 AEs between groups. Conclusions: After 1 year of follow-up, this vaccine is proven safe and effective for preventing COVID-19. A phase III clinical trial involving more subjects should be conducted to establish its efficacy and see other possible side effects.


Subject(s)
COVID-19 , Cancer Vaccines , Adult , Humans , Adolescent , COVID-19/prevention & control , SARS-CoV-2 , COVID-19 Vaccines/adverse effects , Dendritic Cells
3.
BMC Infect Dis ; 22(1): 860, 2022 Nov 17.
Article in English | MEDLINE | ID: mdl-36396997

ABSTRACT

BACKGROUND: Our understanding of the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on bacterial colonization in the children's upper nasopharyngeal tract during the coronavirus infectious disease (COVID-19) pandemic is limited. This study aimed to determine whether there were any differences in bacterial colonization between asymptomatic children with or without a positive SARS-CoV-2 quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) results in the community setting. METHODS: A cross-sectional community-based exploratory study was conducted from March to May 2021 in Semarang, Central Java Province, Indonesia. Using stored nasopharyngeal swabs collected from children under 18 years as a contact tracing program, we performed a real-time quantitative (qPCR) for the most important bacterial colonizing pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Klebsiella pneumoniae. RESULTS: Swabs from a total of 440 children were included in this study, of which 228 (51.8%) were RT-qPCR-confirmed SARS-CoV-2 positive. In the 440 children, colonization rates were highest for H. influenzae (61.4%), followed by S. pneumoniae (17.5%), S. aureus (12.0%), and K. pneumoniae (1.8%). The co-occurrence of both S. pneumoniae and H. influenzae in the upper respiratory tract was significantly associated with a SARS-CoV-2 negative RT-qPCR. In contrast, colonization with only S. aureus was more common in SARS-CoV-2-positive children. CONCLUSION: Overall, this exploratory study concludes that there is a significant difference in the bacterial nasopharyngeal colonization pattern between SARS-CoV-2 positive and negative in asymptomatic children in the community in Indonesia.


Subject(s)
COVID-19 , Pandemics , Child , Humans , Adolescent , SARS-CoV-2 , COVID-19/epidemiology , Staphylococcus aureus , Cross-Sectional Studies , Haemophilus influenzae/genetics , Streptococcus pneumoniae/genetics
4.
BMC Infect Dis ; 20(1): 179, 2020 Feb 27.
Article in English | MEDLINE | ID: mdl-32103771

ABSTRACT

BACKGROUND: The burden of leptospirosis in Indonesia is poorly understood. Data from an observational study conducted from 2013 to 2016 in seven cities across Indonesia was used to estimate the incidence of leptospirosis and document its clinical manifestations in patients requiring hospitalization. METHODS: Specimens from patients hospitalized with acute fever were collected at enrollment, 14-28 days, and 3 months. Demographic and clinical information were collected during study visits and/or retrieved from medical records and double-entered into clinical report forms. After initially screening for dengue virus and other pathogens, specimens were tested at a central Reference Laboratory for anti-Leptospira IgM using commercial ELISA kits and for Leptospira DNA using an in-house quantitative real-time PCR assay. RESULTS: Of 1464 patients enrolled, 45 (3.1%) confirmed cases (by PCR and/or sero-coversion or four-fold increase of IgM) and 6 (0.4%) probable cases (by high titer IgM) of leptospirosis were identified by the Reference Laboratory. Disease incidence at sites ranged from 0 (0%) cases in Denpasar to 17 (8.9%) cases in Semarang. The median age of patients was 41.2 years (range of 5.3 to 85.0 years), and 67% of patients were male. Twenty-two patients (43.1%) were accurately diagnosed at sites, and 29 patients (56.9%) were clinically misdiagnosed as having another infection, most commonly dengue fever (11, 37.9%). Clinically, 20 patients (39.2%) did not present with hyperbilirubinemia or increased creatinine levels. Two patients (3.9%) died, both from respiratory failure. Fifteen patients (29.4%) clinically diagnosed with leptospirosis at sites were negative based on IgM ELISA and/or PCR at the Reference Laboratory. CONCLUSIONS: Leptospirosis remains an important cause of hospitalization in Indonesia. It can have diverse clinical presentations, making it difficult to differentiate from other common tropical infections. PCR combined with ELISA is a powerful alternative to the cumbersome gold-standard microscopic agglutination test, particularly in resource-limited settings.


Subject(s)
Leptospirosis/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Antibodies, Bacterial/blood , Child , Female , Humans , Immunoglobulin M/blood , Indonesia/epidemiology , Laboratories , Leptospira/immunology , Leptospirosis/epidemiology , Male , Middle Aged , Young Adult
5.
Southeast Asian J Trop Med Public Health ; 43(2): 385-422, 2012 Mar.
Article in English | MEDLINE | ID: mdl-23082591

ABSTRACT

Antimicrobial drug resistance is a problem in both developing and developed countries, in hospitals as well as in the community. Much data exists about antimicrobial resistance in Southeast Asia, but this information is fragmented, being published in different papers from different countries over several decades. We reviewed all available information about antimicrobial resistance in Southeast Asia using the PubMed database, concentrating on bacteria that commonly cause infection. From January 1, 1995 to January 1, 2007, 97 reports were published with accurate data regarding resistance patterns among the major pathogens. Thailand was the country where most of the published data were found. No reports were published for East Timor. From the available data, the following trends were observed: 1) there was a high prevalence of resistance to penicillin among Streptococcus pneumoniae and Neisseria gonorrhoeae; 2) pathogens causing diarrheal diseases are now often resistant to inexpensive, older antibiotics; 3) among Enterobacteriaceae and nonfermenting gram-negative bacteria, resistance to virtually all antibiotic classes has been reported, but it is unclear whether multidrug resistant gram-negative bacteria have emerged as a major problem; 4) the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) is not clear; in some countries, such as Singapore, MRSA is endemic in the health care system. This review shows that antimicrobial resistance to pathogenic bacteria has been and still is on the rise in Southeast Asia. However, there is great variation in resistance by hospital, patient type and country.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Infections/drug therapy , Bacterial Infections/epidemiology , Drug Resistance, Bacterial , Asia, Southeastern/epidemiology , Humans , Prevalence
6.
Trop Med Int Health ; 17(4): 455-61, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22248076

ABSTRACT

OBJECTIVE: To characterise commensal Escherichia coli and other Enterobacteriaceae with reduced susceptibility to cefotaxime that were collected in a large survey carried out among 3995 patients and healthy persons in two urban regions on Java, Indonesia, in 2001-2002. METHODS: The putative extended-spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae were analysed using double-disk synergy tests, isoelectric focusing, PCR assays, DNA sequencing, and pulsed-field gel electrophoresis (PFGE). RESULTS: On the day of discharge after five or more days of hospitalisation, at least 95 of 999 (9.5%) patients carried ESBL-positive Enterobacteriaceae as dominant faecal flora. Six patients were simultaneously colonised with E. coli and Klebsiella pneumoniae isolates with ESBL activity. On admission, only 6 of 998 (0.6%) patients were colonised. Faecal carriage of ESBL-producing Enterobacteriaceae among healthy persons or persons visiting a public health centre was not detected. The 107 ESBL-positive strains included 68 E. coli, 35 K. pneumoniae, and four other Enterobacteriaceae. bla(CTX-M-15) was the most prevalent ESBL in both E. coli (47.1%) and K. pneumoniae (45.7%), but the E. coli O25b-ST131 clone was virtually absent. Other ESBL types found were: SHV-2, -2a, -5, -12, CTX-M-3, -9, -14, and TEM-19. PFGE revealed extensive genetic diversity among the isolates. CONCLUSIONS: In 2001-2002, faecal carriage of ESBL-producing Enterobacteriaceae as dominant flora in Indonesia was almost exclusively hospital-associated. The presence of various bla(ESBL) genes and the extensive genetic diversity among isolates argue against a single/dominant strain outbreak.


Subject(s)
Escherichia coli Infections/epidemiology , Escherichia coli/isolation & purification , Feces/microbiology , Inpatients/statistics & numerical data , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/isolation & purification , beta-Lactamases/isolation & purification , Adult , Cluster Analysis , Electrophoresis, Gel, Pulsed-Field , Escherichia coli/genetics , Escherichia coli Infections/microbiology , Female , Humans , Indonesia/epidemiology , Klebsiella Infections/microbiology , Klebsiella pneumoniae/genetics , Male , Middle Aged , Retrospective Studies , Risk Factors , Sequence Analysis, DNA , Young Adult , beta-Lactamases/genetics
7.
Trop Med Int Health ; 15(10): 1235-43, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20667053

ABSTRACT

SUMMARY OBJECTIVES: To identify determinants of carriage of resistant Staphylococcus aureus in both hospitalized patients and individuals from the community in two urban centres in Indonesia. METHODS: Staphylococcus aureus cultures and data on recent antibiotic use, demographic, socioeconomic, disease-related and healthcare-related variables were collected from 3995 community dwellers and hospitalized persons. Nasal S. aureus carriage was found in 362 persons (9.1%). Logistic regression analysis was performed to identify which variables were independently associated with carriage of resistant S. aureus. RESULTS: The penicillins were the most frequently used antibiotics both in the community and in hospitalized patients. In the community, admission to a hospital was associated with carriage of S. aureus resistant to any of the tested antibiotics [odds ratio (OR) 2.5, 95% confidence interval (95% CI) 1.3-4.9] and any tetracycline resistance (OR 2.4, 95% CI 1.1-5.1). Having no symptoms was associated with less carriage of S. aureus with resistance to any of the tested antibiotics (OR 0.5, 95% CI 0.3-0.9) and any tetracycline resistance (OR 0.5, 95% CI 0.3-0.9). Crowding (OR 4.5, 95% CI 1.2-4.9) and low income (OR 8.9, 95% CI 1.8-43.9) were associated with multidrug resistance. In hospitalized patients, the use of penicillins was associated with resistance to any of the tested antibiotics (OR 3.9, 95% CI 1.4-11.6) and any tetracycline resistance (OR 3.7, 95% CI 1.1-12.0). CONCLUSIONS: Antibiotic policies including proper diagnosis, treatment and drug delivery process should be made by healthcare providers in Indonesia to help limit the emergence of antibiotic resistance.


Subject(s)
Carrier State/diagnosis , Staphylococcal Infections/epidemiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Hospitalization , Humans , Indonesia/epidemiology , Logistic Models , Microbial Sensitivity Tests , Nasal Cavity/microbiology , Risk Factors , Socioeconomic Factors , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Tetracycline Resistance
8.
J Microbiol Methods ; 75(2): 177-81, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18585805

ABSTRACT

Although a variety of techniques are available for antimicrobial susceptibility testing, disk diffusion methods remain the most widely used. We compared the accuracy of disk diffusion zone diameters as obtained by manual zone measurements in a low resource country (Indonesia) to that by automated zone measurements (Oxoid aura image system) in a high resource setting (the Netherlands) to determine susceptibility categories (sensitive, intermediate susceptible or resistant). A total of 683 isolates were studied, including 294 Staphylococcus aureus, 195 Escherichia coli and 194 other Enterobacteriaceae. Antimicrobial agents included tetracycline, oxacillin, gentamicin, erythromycin, trimethoprim/sulfamethoxazole and chloramphenicol for S. aureus and ampicillin, gentamicin, cefotaxime, ciprofloxacin, trimethoprim/sulfamethoxazole, and chloramphenicol for E. coli and other Enterobacteriaceae. Of the 4098 drug-organism combinations, overall category agreement (CA), major discrepancy (MD) and minor discrepancy (mD) between the two methods were 82.4% (3379/4098), 6.0% (244/4098) and 11.6% (475/4098), respectively. One hundred and sixty three of 244 MDs were resolved using reference broth microdilution method. Overall very major error (VME), major error (ME) and minor error (mE) of manual zone measurement were 28.8%, 45.4% and 4.9%, respectively and for the aura image system 4.9%, 16.0% and 4.9%, respectively. The results of this study indicate that the disk diffusion method with manual zone measurement in Indonesia is reliable for susceptibility testing. The use of an automated zone reader, such as the aura image system, will reduce the number of errors, and thus improve the accuracy of susceptibility test results for medically relevant bacteria.


Subject(s)
Anti-Bacterial Agents/pharmacology , Disk Diffusion Antimicrobial Tests/methods , Enterobacteriaceae/drug effects , Image Processing, Computer-Assisted/methods , Staphylococcus aureus/drug effects , Automation , Humans , Indonesia , Netherlands , Quality Control , Reproducibility of Results
9.
Int J Infect Dis ; 12(6): 622-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18396084

ABSTRACT

OBJECTIVES: To estimate the antibiotic use of individuals visiting public healthcare facilities in Indonesia and to identify determinants of use against a background of high resistance rates. METHODS: Patients on admission to hospital (group A), visiting a primary health center (group B), and healthy relatives (group C) were included in the study. A questionnaire on demographic, socioeconomic, and healthcare-related items including health complaints and consumption of antibiotics was used. Logistic regression was performed to determine the co-variables of antibiotic use. RESULTS: Of 2996 individuals interviewed, 486 (16%) had taken an antibiotic. Compared to group C (7% consumption), groups B and A exhibited a three-fold and four-fold higher use of antibiotics, respectively. Respiratory (80%) and gastrointestinal (13%) symptoms were most frequent. Aminopenicillins and tetracyclines accounted for 80% of the prescribed antibiotics. Similar antibiotics were self-medicated (17% of users). Age less than 18 years and health insurance were independent determinants of antibiotic use. Urban provenance, being adult, male, and having no health insurance were independent determinants of self-medication. CONCLUSIONS: In addition to health complaints, other factors determined antibiotic consumption. In view of the likely viral origin of respiratory complaints and the resistance of intestinal pathogens, most antibiotic use was probably unnecessary or ineffective. Future interventions should be directed towards healthcare providers.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Health Care Surveys , Hospitals, Teaching , Rural Health Services , Urban Health Services , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Gastrointestinal Diseases/drug therapy , Hospitalization , Humans , Indonesia , Infant , Infant, Newborn , Interviews as Topic , Male , Middle Aged , Practice Patterns, Physicians' , Public Policy , Respiratory Tract Infections/drug therapy , Surveys and Questionnaires , Young Adult
10.
J Clin Microbiol ; 46(6): 1989-95, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18434555

ABSTRACT

Few data on the molecular characteristics and epidemiology of Staphylococcus aureus from Indonesia are available. The purpose of the present study was to define S. aureus reservoirs in both the Indonesian community and hospital using a collection of 329 nasal carriage isolates obtained during a survey of 3,995 healthy individuals and patients from Java, Indonesia. Only one strain (0.3%) was identified as methicillin-resistant S. aureus by mecA gene PCR. The Panton-Valentine leukocidin (PVL) genes were detected in 35 methicillin-sensitive S. aureus strains (10.6%). Molecular typing by pulsed-field gel electrophoresis of the 329 isolates showed extensive genetic diversity among both PVL-positive and PVL-negative strains. In Surabaya, Indonesia, however, a cluster was identified that was strongly associated with the presence of the PVL locus (P < 0.0001). As determined by high-throughput amplified fragment length polymorphism, PVL-positive strains occurred throughout all major AFLP clusters (I to IV). Multilocus sequence typing of a subset of isolates showed that most PVL-positive strains belonged to sequence type (ST) 188, while most PVL-negative isolates belonged to ST45. The high prevalence of PVL-positive S. aureus strains in certain regions of Indonesia is of concern since these strains may cause severe infections in the community and in hospitals.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Toxins/genetics , Carrier State/epidemiology , Carrier State/microbiology , Exotoxins/genetics , Leukocidins/genetics , Methicillin/pharmacology , Nasal Cavity/microbiology , Staphylococcus aureus/drug effects , Electrophoresis, Gel, Pulsed-Field , Humans , Indonesia/epidemiology , Molecular Epidemiology , Polymorphism, Restriction Fragment Length , Prevalence , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/classification , Staphylococcus aureus/genetics
11.
Emerg Infect Dis ; 11(9): 1363-9, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16229763

ABSTRACT

In a recent, population-based survey of 3,996 persons in Indonesia, fluoroquinolone (FQ)-resistant Escherichia coli was prevalent in the fecal flora of 6% of patients at hospital admission and 23% of patients at discharge, but not among healthy relatives or patients visiting primary healthcare centers (2%). Molecular typing showed extensive genetic diversity with only limited clonality among isolates. This finding suggests that independent selection of resistant mutants occurs frequently. FQ-resistant isolates exhibited a higher rate of spontaneous mutation, but sparser virulence profiles, than FQ-susceptible isolates from the same population. The resistant isolates belonged predominantly to phylogenetic groups A (57%) and B1 (22%) but also to the moderately virulent group D (20%). Hypervirulent strains from the B2 cluster were underrepresented (1%). Because FQ-resistant E. coli can cause disease, especially nosocomial infections in immunocompromised patients, spread of such strains must be stopped.


Subject(s)
Anti-Infective Agents/pharmacology , Escherichia coli/drug effects , Fluoroquinolones/pharmacology , Genetics, Population , Phylogeny , Drug Resistance, Bacterial/genetics , Humans , Indonesia , Microbial Sensitivity Tests , Molecular Biology
SELECTION OF CITATIONS
SEARCH DETAIL
...